Comparative pharmacokinetics of Gentamicin in laying hens
Çalışmada, yumurtlayan tavuklara damar içi, kas içi ve deri altı yolla verilen gentamisin sülfatın (5 mg/kg canlı ağırlık) karşılaştırmalı farmakokinetiğinin belirlenmesi amaçlandı. 24 tavuğa ilaç uygulandıktan sonra kan örnekleri 0 (uygulama öncesi), 0.083, 0.166, 0.25, 0.5, 0.75, 1, 2, 4, 8, 12, 24, 36 ve 48. saatlerde toplandı. Gentamisin konsantrasyonları Avrupa Birliği tarafından önerilen yöntemde modifikasyon yapılarak belirlendi. Gentamisinin toplam konsantrasyonu (C1, C2 ve C1a) ölçüldü. En düşük belirlenme limiti 0.01 μg/ml olarak hesaplandı. Non-kompartmental farmakokinetik analizleri Excel ile çalışan program olan PK solver ile belirlendi. Damar içi uygulamayı takiben plazma konsantrasyonu zaman eğrisinin altında kalan alan (AUC0-∞), ilk hız atılma sabitesi (λz), yarı-ömür (t1/2λz) ve ortalama tutulma zamanı (MRT) sırasıyla 224.46 μg/mL saat, 0.06 saat-1, 11.52 saat ve 9.50 saat olarak ölçüldü. Kas içi ve deri altı uygulamadan sonra ortalama maksimum plazma konsantrasyonu (Cmax) sırasıyla26.64 ve 36.92 μg/mL, maksimum konsantrasyona ulaşmak için geçen zaman (Tmax) ise aynı (0.75 saat) olarak belirlendi. Yine kas içi ve deri altı uygulamadan sonra sırasıyla t1/2λz 8.35 ve 8.24 saat, MRT ise 11.05 ve 9.79 saat olarak ölçüldü. Kas içi ve deri altı uygulama arasında Cmax değerleri hariç ve damar içi ile diğer uygulamalar arasında t1/2λz değerleri hariç tutulursa önemli farklılıklar olmadığı sonucuna varılmıştır.
Yumurta tavuklarında Gentamisinin karşılaştırmalı farmakokinetiği
The aim of this study was to compare pharmacokinetics of gentamicin sulphate (5 mg/kg body weight) after single intravenous, intramuscular and subcutaneous administration in laying hens. Blood samples were collected at time 0 (pretreatment), and at 0.083, 0.166, 0.25, 0.5, 0.75, 1, 2, 4, 8, 12, 24, 36 and 48 h after drug administration in 24 laying hens. Gentamicin concentrations were determined using the HPLC method recommended by the European Union by some modifications. The total concentration of the gentamicin (C1, C2 and C1a) was calculated. The lowest detection limit was 0.01 μg/ml. Noncompartmental pharmacokinetic analyses were performed using Excel add-in program, PK solver. Following IV administration the area under the plasma time-concentration curve from time zero to infinity (AUC0-∞), first-order elimination rate constant (λz), terminal half-life (t1/2λz) and mean residence time (MRT) were 224.46 μg/mL h, 0.06 h-1, 11.52 h and 9.50 h, respectively. After i.m. and s.c. dosing, the mean maximum plasma concentrations (Cmax) were 26.64 and 36.92 μg/mL, achieved at a same post-injection times (Tmax) of 0.75 h, respectively. The t1/2λz was 8.35 and 8.24 h, the MRT was 11.05 and 9.79 h, respectively, after IM and SC administration. There are no significant between IM and SC administration excluding the Cmax values and between i.v. and other administration excluding the t1/2λz values.
___
- 1. EMEA: Gentamicin Summary Report (1). The European Agency for the Evaluation of Medicinal Products, Committee for Veterinary Medicinal Products, EMEA/MRL/003/95, 1995.
- 2. Goetting V, Lee KA, Tell LA: Pharmacokinetics of veterinary drugs in laying hens and residues in eggs: A review of the literature. J Vet Pharmacol Ther, 34, 521-556, 2011.
- 3. Metiner K, Ozkan O, Ak S: Antibacterial effects of ethanol and acetone extract of Plantago major L. on Gram positive and Gram negative bacteria. Kafkas Univ Vet Fak, 18, 503-505, 2012.
- 4. EMEA: Gentamicin Summary Report (2). The European Agency for the Evaluation of Medicinal Products, Committee for Veterinary Medicinal Products, EMEA/MRL/729/00-Final, 2000.
- 5. Botsoglou NA, Fletouris DJ: Drug Residues in Food. Marcel Dekker, Inc., New York, NY, 2001.
- 6. Ergin-Kaya S, Filazi A: Determination of antibiotic residues in milk samples. Kafkas Univ Vet Fak Derg, 16 (Suppl A): S31-S35, 2010.
- 7. Frazier DL, Jones MP, Orosz SE: Pharmacokinetic considerations of the renal system in birds: Part II. Review of drugs excreted by renal pathways. J Avian Med Surg, 9, 104-121, 1995.
- 8. Filazi A, Sireli UT, Cadirci O: Residues of gentamicin in eggs following medication of laying hens. Br Poult Sci, 46, 580-583, 2005.
- 9. Sireli UT, Filazi A, Cadirci O: Effect of cooking and storage times on gentamicin residues in eggs. Ital J Food Sci, 18, 441-446, 2006.
- 10. Heitzman RJ: Veterinary Drug Residues, 2nd Edn published on behalf of the Commission of European Communities, EUR 15127-EN (Oxford, Blackwell Science), 1994.
- 11. Zhang Y, Huo M, Zhou J, Xie S: PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed, 99, 306-314, 2010.
- 12. Haritova MA, Djeneva HA, Lashev LD, Sotirova PG, Gurov BI, Dyankov VN: Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the contex of pharmacokinetic-pharmacodynamic relationship. J Vet Pharmacol Ther, 27, 381-384, 2004.
- 13. Pedersoli WM, Ravis WR, Askins BS, Krista LM, Spano JS, Whiteside JF, Tolbert DS: Pharmacokinetics of single doses of gentamicin given intravenously and intramuscularly to turkeys. J Vet Pharmacol Ther, 12, 124-132, 1989.
- 14. Bird JE, Miller KW, Larson AA: Pharmacokinetics of gentamicin in birds of prey. Am J Vet Res, 44, 1245-1249, 1983.
- 15. Pedersoli WM, Ravis WR, Askins BS, Krista LM, Spano JS, Whiteside JF, Tolbert DS: Pharmacokinetics of single-dose intravenous or intramuscular administration of gentamicin in roosters. Am J Vet Res, 51, 286-289, 1990.
- 16. Abu-Basha EA, Idkaidek NM, Al-Shunnag AF: Comparative pharmaco- kinetics of gentamicin after intravenous, intramuscular, subcutaneous and oral administration in broiler chickens. Vet Res Commun, 31, 765-773, 2007.
- 17. Xiong Y, Caillon J, Kerguerius MF: Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother, 41, 823-826, 1997.
- 18. Riviere JE, Spoo JW: Veterinary Pharmacology and Therapeutics. 7th ed., Iowa State University Press, Ames, IA, 1995.